2006
DOI: 10.1016/j.neuroscience.2005.12.036
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative analysis of amyloid plaques in a mouse model of Alzheimer’s disease by phase-contrast X-ray computed tomography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
36
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(37 citation statements)
references
References 41 publications
1
36
0
Order By: Relevance
“…The neuritic plaques [1] composed of ␤-amyloid (A␤) peptide in the brain of Alzheimer's disease (AD) patients, the most common cause of senile dementia [2], is primarily composed of A␤ and to a lesser extent A␤ . These peptides are used as the hallmark indicators of AD [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…The neuritic plaques [1] composed of ␤-amyloid (A␤) peptide in the brain of Alzheimer's disease (AD) patients, the most common cause of senile dementia [2], is primarily composed of A␤ and to a lesser extent A␤ . These peptides are used as the hallmark indicators of AD [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…The following chapter gives an outlook on the application of propagation-based phase-contrast tomography for imaging of structural changes occurring during neurodegenerative diseases, in particular at the examples of multiple sclerosis [22], Alzheimer's disease [119,137] and a mouse model for ischemic stroke [37].…”
Section: Outlook: 3d Histology Of Neurodegenerative Diseasesmentioning
confidence: 99%
“…Very high field micro-MRI has shown the ability to visualize in vivo plaques in mice [4]. More recently, phase contrast X-ray imaging, a synchrotron X-ray technique similar to DEI, was used to image individual plaques in AD-model transgenic mice ex vivo [5]. These new imaging methods use completely different contrast mechanisms to achieve the same goal of high-resolution, in vivo imaging of amyloid plaques.…”
Section: Why Bother?mentioning
confidence: 99%